The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book by Ann Mullally, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Ann Mullally, MD ISBN: 9780323532365
Publisher: Elsevier Health Sciences Publication: July 14, 2017
Imprint: Elsevier Language: English
Author: Ann Mullally, MD
ISBN: 9780323532365
Publisher: Elsevier Health Sciences
Publication: July 14, 2017
Imprint: Elsevier
Language: English

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

More books from Elsevier Health Sciences

Cover of the book Atlas of Laparoscopic and Robotic Urologic Surgery E-Book by Ann Mullally, MD
Cover of the book Soigner par la méditation by Ann Mullally, MD
Cover of the book Gray's Anatomy E-Book by Ann Mullally, MD
Cover of the book Dermatology Essentials E- Book by Ann Mullally, MD
Cover of the book Fundamentals of Body CT E-Book by Ann Mullally, MD
Cover of the book Metabolism of amino acids by Ann Mullally, MD
Cover of the book Current Management of Diabetic Retinopathy by Ann Mullally, MD
Cover of the book Pediatric Hospital Medicine and Pediatric Palliative Care, An Issue of Pediatric Clinics, E-Book by Ann Mullally, MD
Cover of the book vol 1: Pericardium and Heart by Ann Mullally, MD
Cover of the book Chronic Pain, An Issue of Physical Medicine and Rehabilitation Clinics of North America, E-Book by Ann Mullally, MD
Cover of the book Catheter Ablation of Cardiac Arrhythmias E-book by Ann Mullally, MD
Cover of the book Relation d'aide en soins infirmiers by Ann Mullally, MD
Cover of the book The Teaching Files: Head and Neck Imaging E-Book by Ann Mullally, MD
Cover of the book Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America, E-Book by Ann Mullally, MD
Cover of the book Joints by Ann Mullally, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy